Home/Filings/4/0001237899-05-000013
4//SEC Filing

RUPP RANDALL 4

Accession 0001237899-05-000013

CIK 0000872589other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 3:15 PM ET

Size

24.8 KB

Accession

0001237899-05-000013

Insider Transaction Report

Form 4
Period: 2005-01-05
RUPP RANDALL
SVP, Manuf & Process Sciences
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2005-01-05+8,5949,999 total
    Exercise: $8.50Exp: 2011-01-05Common Stock (8,594 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2005-01-05+3,4313,431 total
    Exercise: $8.50Exp: 2012-12-20Common Stock (3,431 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2005-01-055,1470 total
    Exercise: $19.43Exp: 2012-12-20Common Stock (5,147 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2005-01-05+29,90233,333 total
    Exercise: $8.50Exp: 2012-12-20Common Stock (29,902 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2005-01-054,2160 total
    Exercise: $37.78Exp: 2010-12-21Common Stock (4,216 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2005-01-05+1,4051,405 total
    Exercise: $8.50Exp: 2011-01-05Common Stock (1,405 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2005-01-05+15,00015,000 total
    Exercise: $8.50Exp: 2011-12-18Common Stock (15,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2005-01-0544,8530 total
    Exercise: $19.43Exp: 2012-12-20Common Stock (44,853 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2005-01-0525,7840 total
    Exercise: $37.78Exp: 2010-12-21Common Stock (25,784 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2005-01-0530,0000 total
    Exercise: $28.01Exp: 2011-12-18Common Stock (30,000 underlying)
Footnotes (4)
  • [F1]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 20, 2002 and vests in four equal annual installments, commencing one year after the date of grant.
  • [F2]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 21, 2000 and vests in five equal annual installments, commencing one year after the date of grant.
  • [F3]The option becomes fully exercisable with respect to all shares underlying the option if the Company's products achieve aggregate, worldwide gross sales of at least US$100 million during any consecutive twelve-month period based on sales directly by the Company and/or its licensees, affiliates, and distributors (the "Milestone Date") unless the Milestone Date occurs before the third anniversary of the grant date, in which case all of the shares underlying the option become fully vested on the third anniversary of the grant date.
  • [F4]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 18, 2001 and vests in four equal annual installments, commencing one year after the date of grant.

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

Entity typeother

Related Parties

1
  • filerCIK 0001226688

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 3:15 PM ET
Size
24.8 KB